Most Recent Articles by Suzanne Bujara
Statin therapy is the first line of defense against high LDL-C and the risk for atherosclerotic cardiovascular disease, the leading cause of morbidity and mortality in individuals with diabetes.
Nutraceuticals may offer a solution to patients who cannot tolerate statins because of severe muscle pain.
The transition from pediatric to adult care for type 1 diabetes should be a gradual process, with a plan to make the change when the patient is ready, not at a pre-determined time.
Environmental causes of T2D and other metabolic disorders are often overlooked; a new body of evidence, however, is changing the clinical thinking about mitigating these effects on those at high risk of T2D.
Knowing that certain characteristics increase the risk for dermatology patients who may have metabolic syndrome will enable clinicians to identify patients who may have specific cardiovascular risks.
More Articles by Suzanne Bujara
Endocrinology Advisor Articles
- Heritability of BMI Stronger in Obesogenic Environments
- Maternal Gluten Intake Associated With Risk for Type 1 Diabetes in Offspring
- Bone-Derived Factors in the Treatment of Diabetes
- Thyroid Hormone Therapy Not Beneficial for Subclinical Hypothyroidism
- Deep Learning Algorithm Efficiently Detects Vision-Threatening Diabetic Retinopathy
- Bacillus Calmette-Guerin Vaccination Lowers HbA1c in Type 1 Diabetes
- Early Manifestations, Sex Differences May Aid in Acromegaly Diagnosis
- Predictive Variables for Permanent vs Transient Congenital Hypothyroidism
- Aetna-CVS Merger Approved
- Benefits and Ethical Considerations of Using AI for Predicting Incapacitated Patients' Consent